XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock Issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive (loss)
Non- controlling interests
Treasury shares
Total
Balance at Dec. 31, 2020 $ 79,310   $ 225,278,113 $ 1,230,511 $ (183,984,311) $ (239,609) $ 7,735 $ (4,066,610) $ 52,406,828
Balance (in Shares) at Dec. 31, 2020 79,310,249 14,101,689           (144,206)  
Net income (loss)     52,329,617   21,995   52,351,612
Share-based compensation for employee and director stock awards   333,365 333,365
Share-based compensation for employee and director stock awards (in Shares)                
Common stock issued to employees and directors for stock awards $ 305   (305)
Common stock issued to employees and directors for stock awards (in Shares) 305,165              
Common stock issued to investors $ 8,940   15,621,071 15,630,011
Common stock issued to investors (in Shares) 8,939,976              
Foreign currency translation adjustment   1,479,963 (5,971) 1,473,992
Foreign currency translation adjustment (in Shares)                
Balance at Sep. 30, 2021 $ 88,555   241,232,244 1,230,511 (131,654,694) 1,240,354 23,759 $ (4,066,610) 122,195,808
Balance (in Shares) at Sep. 30, 2021 88,555,390 14,101,689           (144,206)  
Balance at Jun. 30, 2021 $ 88,538   241,141,468 1,230,511 (151,674,428) 997,013 20,355 $ (4,066,610) 101,838,536
Balance (in Shares) at Jun. 30, 2021 88,538,723 14,101,689           (144,206)  
Net income (loss)         20,019,734   3,487   20,023,221
Share-based compensation for employee and director stock awards     90,793           90,793
Common stock issued to employees and directors for stock awards $ 17   (17)            
Common stock issued to employees and directors for stock awards (in Shares) 16,667                
Foreign currency translation adjustment           243,341 (83)   243,258
Balance at Sep. 30, 2021 $ 88,555   241,232,244 1,230,511 (131,654,694) 1,240,354 23,759 $ (4,066,610) 122,195,808
Balance (in Shares) at Sep. 30, 2021 88,555,390 14,101,689           (144,206)  
Balance at Dec. 31, 2021 $ 88,849   241,946,362 1,230,511 (122,498,259) 2,489,017 7,593,014 $ (4,066,610) 140,884,573
Balance (in Shares) at Dec. 31, 2021 88,849,222 14,101,689           (144,206)  
Net income (loss)         1,249,353   (401,313)   848,040
Share-based compensation for employee and director stock awards   57,152 57,152
Share-based compensation for employee and director stock awards (in Shares)                
Capital injection     1,050,060       383,127   1,433,187
Common stock issued to employees and directors for stock awards $ 286   (286)
Common stock issued to employees and directors for stock awards (in Shares) 285,842              
Foreign currency translation adjustment   (14,871,500) (748,972) (15,620,472)
Foreign currency translation adjustment (in Shares)                
Balance at Sep. 30, 2022 $ 89,135   243,053,288 1,230,511 (121,248,906) (12,382,483) 6,825,856 $ (4,066,610) 127,602,480
Balance (in Shares) at Sep. 30, 2022 89,135,064 14,101,689           (144,206)  
Balance at Jun. 30, 2022 $ 89,135   241,991,981 1,230,511 (121,248,616) (4,240,719) 8,075,148 $ (4,066,610) 135,932,519
Balance (in Shares) at Jun. 30, 2022 89,135,064 14,101,689           (144,206)  
Net income (loss)         (290)   (848,438)   (848,728)
Share-based compensation for employee and director stock awards   11,247   11,247
Share-based compensation for employee and director stock awards (in Shares)                
Capital injection     1,050,060       383,127   1,433,187
Foreign currency translation adjustment   (8,141,764) (783,981) (8,925,745)
Foreign currency translation adjustment (in Shares)                
Balance at Sep. 30, 2022 $ 89,135   $ 243,053,288 $ 1,230,511 $ (121,248,906) $ (12,382,483) $ 6,825,856 $ (4,066,610) $ 127,602,480
Balance (in Shares) at Sep. 30, 2022 89,135,064 14,101,689           (144,206)